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Neurotransmitters and neuromodulators, such as dopamine, participate in a wide range
of behavioral and cognitive functions in the adult brain, including movement, cognition,
and reward. Dopamine-mediated signaling plays a fundamental neurodevelopmental role
in forebrain differentiation and circuit formation. These developmental effects, such as
modulation of neuronal migration and dendritic growth, occur before synaptogenesis
and demonstrate novel roles for dopaminergic signaling beyond neuromodulation at the
synapse. Pharmacologic and genetic disruptions demonstrate that these effects are
brain region- and receptor subtype-speciﬁc. For example, the striatum and frontal cortex
exhibit abnormal neuronal structure and function following prenatal disruption of dopamine
receptor signaling. Alterations in these processes are implicated in the pathophysiology
of neuropsychiatric disorders, and emerging studies of neurodevelopmental disruptions
may shed light on the pathophysiology of abnormal neuronal circuitry in neuropsychiatric
disorders.
Keywords: neurodevelopment, frontal cortex, striatum, D1 receptor, D2 receptor, neuropsychiatric disease, dendrite,
migration
INTRODUCTION
Brain development requires a complex interplay of genetic and
environmental factors. Disruption of these elements can affect
neuronal structure, function, or connectivity and can alter devel-
opmental trajectory. In turn, this can lead to long-lasting, even
permanent, effects and contribute to brain disorders later in life
(Finlay, 2001; Lewis and Levitt, 2002; Frederick and Stanwood,
2009; Thompson et al., 2009; Rapoport et al., 2012; Ben-Ari,
2013). Neurodevelopmental alterations in the frontal/prefrontal
cortex and striatum, which are both heavily involved in cog-
nition, memory, emotion, and learning, are likely involved in
the etiology of neuropsychiatric disorders like autism, substance
use disorders, and schizophrenia (Simpson et al., 2010; Lan-
gen et al., 2012; Jonas et al., 2013). These brain regions receive
prominent dopamine (DA) innervations and express DA recep-
tors (Bjorklund and Dunnett, 2007; Tritsch and Sabatini, 2012;
Roeper, 2013). In fact, DA and other neurotransmitters are
expressed even prior to synaptogenesis, and activation of their
receptors during development alters brain structure and connec-
tivity with enduring anatomical and behavioral effects through
adulthood (Schmidt et al., 1996; Spencer et al., 1998; Stanwood
and Levitt, 2001, 2007; Stanwood et al., 2005; Bhide, 2009; Lu
et al., 2009; Zhang et al., 2010; Bellone et al., 2011; Hamilton et al.,
2011; McCarthy et al., 2011). However, the cellular and functional
consequences of these activities are still poorly understood, and
their linkages to speciﬁc diseases are often indirect and poorly
elucidated.
Here we will review evidence for the role of DA receptors in
neurodevelopmental processes with an emphasis on how DA D1
and D2 receptors modulate neuronal morphology in the frontal
cortex and striatum. We will then brieﬂy discuss the relevant
intracellular signaling mechanisms through which DA receptors
modulate neuronal morphology, and conclude with the implica-
tions of altered DA signaling on our understanding of the etiology
and pathophysiology of neuropsychiatric disorders.
ONTOGENY OF DOPAMINERGIC INNERVATION AND
RECEPTOR EXPRESSION PATTERNS
DA innervation and receptor expression are present early in devel-
opment, mature during adolescence, and form stable patterns in
young adulthood. This prolonged developmental timeline pro-
vides a large window of “critical periods” during which potential
disruptors can induce varied effects. For example, a landmark
study by Andersen et al. (2002) showed that repeated exposure
to methylphenidate (Ritalin) during the juvenile period reduces
cocaine reward in adulthood, whereas adult methylphenidate
exposure does not confer this protection.
Alterations in DA innervation patterns and receptor expression
have been found in several brain disorders, including psychiatric
disease. A decrease in DAergic axons in deep layers of medial
prefrontal cortex and decreased D1 receptor binding occurs in
schizophrenic patients (Okubo et al., 1997; Akil et al., 1999). In
addition, increased D2 receptor binding in the striatum has been
observed in patients with ADHD and depression (D’Haenen and
Bossuyt, 1994; Shah et al., 1997). Anunderstanding of the develop-
mental timeline of the DA system and points at which the normal
developmental trajectory can be altered are crucial to explore the
implications of DAergic disruption.
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The frontal cortex and striatum are innervated by DA-
containing axons fromthemesencephalicDAnuclei bymid-to-late
gestation in rodents (Verney et al., 1982; Kalsbeek et al., 1988;
Voorn et al., 1988), the predominant animal models used to study
the developmental roles of DA. Voorn et al. (1988) demonstrated
that DA innervation develops in well-deﬁned spatiotemporal gra-
dients in the lateral ganglionic eminence (presumptive striatum)
that begins by embryonic day (E) 14 and coincides with striatal
neurogenesis and cell differentiation. The rat developing cortex
receives DAergic ﬁbers that pass through the striatum, with inner-
vation occurring in a lateral (E16) to medial fashion (E19). At
birth, DAergic ﬁbers are concentrated in the developing layer VI
of frontal cortex. Fiber density increases over time in the deep
layers of cortex with some ﬁbers innervating more superﬁcial lay-
ers in discrete cortical regions as the more superﬁcial cortical
layers develop (Kalsbeek et al., 1988). Mature DAergic innerva-
tion patterns are established in both regions by postnatal day 60.
Studies in other species suggest that these sequences of events
are very well conserved evolutionarily, although the exact tim-
ings are of course quite different based on gestation length (see
below).
Dopamine receptor expression develops in concert with DAer-
gic innervation. DA receptors are part of the G-protein coupled
receptor superfamily and can be classiﬁed into two subgroups
based on sequence, pharmacology, and G protein signaling: D1-
like, which includes D1 and D5 receptors, and D2-like, which
includes D2, D3, and D4 receptors (Missale et al., 1998; Beaulieu
and Gainetdinov, 2011). Even before DAergic afferents have fully
occupied the striatum or cortex, the main two DA receptor sub-
types (D1 and D2 receptors) are already present (Schambra et al.,
1994; Araki et al., 2007; Sillivan and Konradi, 2011). Higher levels
of expression for both subtypes are found in the striatum com-
pared to frontal cortex from development to adulthood (Araki
et al., 2007; Sillivan and Konradi, 2011), and the D1 receptor
subtype is expressed at higher levels than the D2 receptor sub-
type in both regions (Boyson et al., 1986; Neisewander et al., 1991;
Couppis et al., 2008). D3, D4, and D5 receptors are consistently
expressed at lower levels but still are present even during pre-
natal development. For example, D3 and D5 receptor mRNA
is ﬁrst found in the striatum at E12 and frontal cortex by E15
(Araki et al., 2007). However, D4 receptor mRNA, which is also
present in the striatum at E12 and frontal cortex by E15, has its
highest expression during embryonic development (Araki et al.,
2007). D4 receptor mRNA decreases after birth with a more
signiﬁcant drop in expression seen in the frontal cortex (Nair
and Mishra, 1995). D3 receptors are also are expressed tran-
siently within the early postnatal somatosensory cortex during
a key critical period of plasticity (Gurevich and Joyce, 2000;
Gurevich et al., 2001), although their function there remains
unknown.
Dopaminergic development continues postnatally and impacts
forebrain synaptogenesis and connectivity. For example,D1 recep-
tor pruning is speciﬁcally associated with maturation of the
excitation-inhibition balance in frontal cortex during adolescence
(Andersen et al., 2000). Jung and Bennett (1996) demonstrated
that D1 receptor expression steadily declines after the fourth post-
natal week, which has been conﬁrmed by others and is illustrated
in Figure 1C (Andersen et al., 2000; Araki et al., 2007; Brenhouse
et al., 2008). Cortical circuits and processing relies on connec-
tivity and excitability of both excitatory glutamatergic pyramidal
neurons and inhibitory GABAergic interneurons. Disruptions
of excitation-inhibition balance in the frontal cortex have been
reported in patients with schizophrenia, autism, major depres-
sive disorder, and obsessive compulsive disorder (Harada et al.,
2011; Cornew et al., 2012; Radhu et al., 2013), and many of
these patients present with a ﬁrst episode around adolescence.
Risk of substance abuse disorders also increases during adoles-
cence (O’Brien and Anthony, 2005). Genetically mediated DA
variability has been suggested to shape complex behaviors emerg-
ing in adolescence, such as impulsivity and sensation seeking
(Padmanabhan and Luna, 2013). DAergic regulation of frontal
cortex output to subcortical areas mediates drug seeking behav-
ior, with D1 receptor activation enhancing cortically driven drug
seeking (Piazza et al., 1991; Kalivas et al., 2005). Moreover, cor-
tical output neurons to the nucleus accumbens, a subcortical
reward area, express higher levels of D1 receptors during adoles-
cence in rodent models. This correlates with increased sensitivity
to cocaine conditioned place preference. Brenhouse et al. (2008)
found this increased preference to be enhanced with microin-
jections of D1-like receptor agonist in the prefrontal cortex but
blunted with D1-like receptor antagonist, demonstrating the
importance of D1 receptor signaling in heightened adolescent
sensitivity to cocaine preference. This work demonstrates how
the prolonged development of the DA system allows for vulner-
ability into adolescence. Thus, inappropriate alterations in D1
receptor signaling during adolescent cortical maturation could
play a signiﬁcant role in the development of neuropsychiatric
diseases.
Phylogenetic differences in brain development exist between
rodents and higher mammals (Workman et al., 2013). In regards
to DA, monkeys and humans have more widespread cortical DA
input than rodents and signiﬁcantly denser DAergic innerva-
tion in motor, premotor, and supplementary motor association
cortices (Berger et al., 1988, 1991; Gaspar et al., 1989; Meador-
Woodruff et al., 1996). HumanDAergic innervationoccurs early in
development and is strongly established by mid-gestation (Olson
et al., 1973; Verney et al., 1991, 1993; Zecevic and Verney, 1995).
The density of DAergic ﬁbers to the prefrontal cortex in non-
human primates increases during preadolescence, peaks during
adolescence, and then declines (Rosenberg and Lewis, 1995). This
evolution of the cortical DAergic system in primates suggests a
more substantial role for DAergic innervation in development
in more evolved species. The increased inﬂuence of DA in the
human brain is exempliﬁed by the increase in neuropsychiatric
disease onset during adolescence, the time period when the DA
system matures. The role of DA system development in neuropsy-
chiatric disease vulnerability is an active area of research, and
hopefully, the ﬁeld will soon understand how to correct aberrant
DA development in these vulnerable individuals.
STRIATAL AND CORTICAL DOPAMINERGIC PATHWAYS
The striatum receives DAergic innervation from the substantia
nigra pars compacta, which is known as the nigrostriatal path-
way (shown in Figure 2). These DAergic afferents synapse on
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FIGURE 1 | (A) During midgestation DA receptors have subtype-speciﬁc
effects both on neuronal proliferation and interneuron migration; (B) During
late-gestation DA receptors continue to be bioactive and regulate dendritic
complexity of both cortical pyramidal neurons and striatal medium spiny
projection neurons in a subtype-speciﬁc manner; (C) DA receptor expression
typically peaks during adolescence and then declines. For D1 receptors in the
frontal cortex, this is not just a reduction in total receptors per neuron, but
rather a “pruning” of a subpopulation of D1 receptors that are transiently
expressed on the terminals of cortico-accumbens neurons (Andersen et al.,
2000; Brenhouse et al., 2008); (D) Photomicrographs demonstrate the
localization of D1 [red, Drd1-tdTomato reporter (Ade et al., 2011)] and D2
[Drd2-eGFP reporter (Gong et al., 2003)] receptors in the rostral (left) and
caudal (right) striatum of the adult mouse. Note the heavy labeling of D1 and
D2 expressing cells within the CPu and NAc (note very few of these neurons
co-express both receptors). More caudally (right) eGFP-labeled terminals can
be visualized within the GP, representing the D2+ indirect pathway. D1+
axons, in contrast, bundle ventromedially to the GP and will eventually
terminate in the substantia nigra and ventral tegmental area. CPu,
caudate-putamen; Ctx, cortex; GE, ganglionic eminences; GP, globus pallidus,
mFC, medial frontal cortex, and NAc, nucleus accumbens. The brain images
in panels (B) and (C) are courtesy of the Allen Developing Mouse Brain Atlas
and are available from: http://developingmouse.brain-map.org.
two distinct populations of GABAergic projection neurons, which
express either D1 or D2 receptors (demonstrated in Figure 1D;
Shuen et al., 2008; Santana et al., 2009; Ade et al., 2011). These
populations send projections directly to or indirectly through the
globus pallidus (external globus pallidus in primates) to the sub-
stantia nigra pars reticulata and endopeduncular nucleus (internal
globus pallidus in primates) to make up the direct (D1 recep-
tor expressing neurons) and indirect (D2 receptor expressing
neurons) pathways to modulate movement and goal-oriented
behavior (Missale et al., 1998; Beaulieu and Gainetdinov, 2011).
Dysfunction within these pathways is a hallmark feature of multi-
ple movement disorders, such as Parkinsonism and Huntingdon’s
disease. Medications that target DA receptors can also modulate
these pathways. For example, typical antipsychotics modulate this
system by blocking D2 receptors; this action treats positive symp-
toms but can also lead to tardive dyskinesia, a serious side effect
characterized by involuntary, repetitive movements. The impor-
tance of the nigrostriatal DAergic projections onto the direct and
indirect pathway projection neurons is made evident by the devas-
tating symptoms that result from disruption of this pathway, but
other DAergic pathways can also play an important role in disease.
The ventral tegmental area (VTA), another mesencephalic
nucleus, gives rise to two additional DAergic pathways. Projec-
tions from theVTA to limbic areas, such as the nucleus accumbens,
and to the frontal cortex form the mesolimbic and mesocortical
pathways (shown in Figure 2), respectively. In the nucleus accum-
bens, patterns of D1 and D2 receptor expression are similar to
the dorsal striatum (demonstrated in Figure 1D). In addition, the
shell of the nucleus accumbens expresses high levels of D3 recep-
tors (Le Moine and Bloch, 1995). DA receptor expression is lower
in the frontal cortex and found in several types of neurons. In
the frontal cortex, D1 receptors appear to be the most prominent
DA receptor, and both D1 and D2 receptors are found in deep
layer V/VI glutamatergic projection neurons and parvalbumin-
containing GABAergic interneurons (Le Moine and Gaspar, 1998;
Muly et al., 1998). D4 and D5 receptors are expressed at low levels
in frontal cortex (Beaulieu and Gainetdinov, 2011). Importantly,
these pathways and DA receptor expression patterns have great
functional signiﬁcance. The mesolimbic pathway is mainly asso-
ciated with reward, while the mesocortical pathway is associated
with cognitive function. Aberrant reward processing drives sub-
stance abuse disorders, and cognitive dysfunction exists as an often
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FIGURE 2 | Nigrostriatal, mesocortical, and mesolimbic pathways
cartooned in an adult mouse brain in the sagittal plane. Substantia
nigra pars compacta (SN) projects to GABAergic projection neurons in the
dorsal striatum. The ventral tegmental area (VTA) projects to both
subcortical limbic areas and to the medial frontal cortex.
overlooked but devastating feature of many neuropsychiatric dis-
orders (Carter et al., 1998; Bosboom et al., 2004; Medalia and Lim,
2004). Studies of imbalanced mesolimbic and mesocortical DAer-
gic signaling support a potential therapeutic role for DA in reward
and cognitive dysfunction in neuropsychiatric disease (Murphy
et al., 1996; Volkow et al., 1998; Goldman-Rakic et al., 2004). Thus,
DAcan inﬂuencemultiple aspects of humanbehavior bothdirectly
through striatal projections and indirectly through alterations
in reward and cognition (for description of the trajectories of
growing DA axons and signals contributing to topography, see
Prestoz et al., 2012).
DEVELOPMENTAL EFFECTS OF DOPAMINERGIC
MODULATION
DA is one of the earliest neurotransmitters expressed in the
developing brain and plays a signiﬁcant role in the develop-
ment of neuronal cytoarchitecture. The presence of DAergic
projections to the developing cortex and striatum, as well as
DA receptors on precursor cells, places DA in an ideal position
to modulate neuronal development, including cell proliferation,
migration, and differentiation all of which can lead to altered
connectivity and dysfunctional synapses. In fact, genetic and
pharmacologic models of disrupted DA signaling display changes
in cortical and striatal circuitry (Stanwood et al., 2001b, 2005;
Song et al., 2002; Kellendonk et al., 2006; McCarthy et al., 2007;
Zhang et al., 2010). Environmental, social, and inﬂammatory chal-
lenges during sensitive periods of forebrain development also
produce neuro(mal)adaptions in these regions and phenocopy
some aspects of brain disorders (Di Forti et al., 2007; Kern et al.,
2010; Han et al., 2012; Selemon and Friedman, 2013). For exam-
ple, models of prenatal infection, stress, and exposure to drugs of
abuse show long-lasting changes in DA receptor expression and
function and have been associated with increased risk for psychi-
atric disorders (Alonso et al., 1994; Stanwood et al., 2001b; Berger
et al., 2002; Zuckerman et al., 2003; Andersen and Teicher, 2009;
Bhide, 2009; Brown et al., 2012). Taken together, these data have
led our group and others to hypothesize that DAergic modulation
of developmental processes produces long lasting alterations that
contribute to cortical and striatal dysfunction in neuropsychiatric
disorders.
NEUROPROGENITOR PROLIFERATION
The earliest observed developmental effects of altered DA sig-
naling are changes in neuroprogenitor proliferation. Selective
D1-like receptor agonists can decrease incorporation of the cell
cyclemarker bromodeoxyuridine (BrdU) in the developingmedial
frontal cortex and lateral ganglionic eminence, a basal forebrain
progenitor pool that is the source for most striatal neurons (illus-
trated in Figure 1A). Decreased BrdU incorporation is indicative
of less neuronal progenitors undergoing division. Both D1-like
and D2-like receptors contribute to neurogenesis but with oppo-
site effects; blockade of D1-like receptors and activation of D2-like
receptors increase thenumber of neuronal progenitors undergoing
cell division (Ohtani et al., 2003; Popolo et al., 2004). Admin-
istration of the DA precursor L-DOPA during early gestation
decreases cell proliferation (McCarthy et al., 2007), suggesting that
D1 receptor mediated effects may dominate in vivo. Although
these studies did not mechanistically investigate how D1 and
D2 receptors alter BrdU incorporation, another group exam-
ined receptor-induced changes in cell cycle protein expression.
Indeed, D1-like receptor activation promotes downregulation
of cyclin D and upregulation of the cyclin dependent kinase
inhibitor p27Kip1 (Zhang et al., 2005). Cyclin D promotes the
transition from the growth phase to S-phase of the cell cycle
while p27Kip1 inhibits it (Sheaff and Roberts, 1998). In addi-
tion, Raf-1, a component of the mitogen-activated protein kinase
(MAPK) pathway that promotes mitosis, is downregulated by D1-
like receptor activation (Denhardt, 1999; Zhang et al., 2005). The
mechanismbywhich these effects on cell cycle proteins occur is not
known, although it appears to be PKA-independent (Zhang et al.,
2005). The effects of transient differences in cell cycle proteins
have yet to be understood, but small deviations in the number
of cells available to release or receive important developmental
signals could signiﬁcantly alter developmental trajectory. And
although it is beyond the scope of our current review, it is also
worth noting that both acute and chronic DA depletion decreases
subependymal neuronal proliferation (Lewis et al., 1977; Patel
et al., 1977), and DA receptors, especially D3 receptors, can guide
adult neurogenesis as well (Kim et al., 2010; Egeland et al., 2012;
Lao et al., 2013).
MIGRATION
As mentioned above, inappropriate excitation-inhibition balance
in frontal cortex is found in several neuropsychiatric diseases
(Harada et al., 2011; Cornew et al., 2012; Radhu et al., 2013), which
could be partly due to a lack of adequate interneuron migra-
tion. The two main cell types in the frontal cortex, glutamatergic
pyramidal projection neurons and GABAergic interneurons, are
derived from two separate progenitor pools in the developing
rodent forebrain. Pyramidal neurons are produced locally in
the neuroepithelium of the developing cortex and migrate radi-
ally to the appropriate cortical layer. Concurrently, GABAergic
interneurons generated in the basal forebrain in the medial and
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caudal ganglionic eminences migrate tangentially to the cortex
(de Carlos et al., 1996; Wonders and Anderson, 2006). The num-
ber of GABAergic interneurons increases through mammalian
brain evolution beyond what the ganglionic eminences can pro-
vide. Therefore, in primates, GABAergic interneurons are also
produced in the dorsal forebrain and migrate radially through
cortex (Letinic et al., 2002; Petanjek et al., 2009). However, this
tangentially migrating population of interneurons is still a sub-
stantial portion of interneurons produced, and dysregulation of
either population would contribute to neuropsychiatric disease
(Hansen et al., 2013; Ma et al., 2013).
GABAergic neurons in the medial and caudal ganglionic
eminences express DA receptors, and these forebrain regions
receive DAergic innervation during the embryonic period when
migration occurs. The Bhide lab has demonstrated that altering
DA receptor signaling with prenatal cocaine or receptor-speciﬁc
agonists/antagonists disrupts tangential migration (illustrated in
Figure 1A). Prenatal cocaine exposure decreases tangential migra-
tion of cortical GABAergic neurons, perhaps mediated by the
loss of D1 receptor signaling (Jones et al., 2000; Crandall et al.,
2004; Stanwood and Levitt, 2007; McCarthy et al., 2011). In
addition, application of D1-like receptor agonists in mouse
embryonic slice cultures promotes cortical GABAergic neuron
migration whereas D2-like receptor agonism decreases migration
(Crandall et al., 2007). Overexpression of the D1 receptor by in
vitro electroporation increases the effect of D1-like receptor ago-
nists on promoting tangential migration (Crandall et al., 2007).
The basis for opposing D1 vs. D2 receptor effects is not fully
understood, but cytoskeletal reorganization must occur for neu-
ronal migration. D1-like receptor stimulation leads to increased
neurite localization of cytoskeletal elements needed for cell motil-
ity, such as cytoplasmic dyneinmotor protein and tubulin,whereas
D2-like receptor stimulation leads to increased cell body localiza-
tion of these cytoskeletal elements. Crandall et al. (2007) suggest
that this subtype-speciﬁc redistribution of cytoskeletal elements
needed for cell motility leads to opposite effects on neuronal
migration. Elucidation of the molecular pathways responsible
for receptor-dependent modulation of neuronal migration may
provide new targets for the restoration of neurodevelopmental
trajectory.
DENDRITIC AND AXONAL GROWTH
Dendritic and axonal growth are activity-dependent, highly
dynamic processes that remain partially plastic until adulthood
(McAllister, 2000). Disruption of dendritic or axonal growth alters
both the quantity and nature of neural connections. Not sur-
prisingly, anomalies in brain connectivity have been linked to
several neuropsychiatric diseases, including intellectual disability
and schizophrenia (Kaufmann andMoser,2000; Black et al., 2004).
In fact, DA receptor activation modulates dendritic structure,
creating subtle but signiﬁcant changes in brain architecture that
may increase vulnerability toneurological and/orneuropsychiatric
disease.
In this regard, activation of DA receptors inﬂuences axonal
and dendritic growth in a subtype-speciﬁc manner. Primary
cultures have been the primary model to test the in vitro
effects of DAergic modulation on neurite outgrowth, a term
to describe both the developing axon and dendrite. Several
groups demonstrated that D1-like receptor agonists signiﬁcantly
reduce neurite outgrowth in frontal cortical neuronal cultures
(Reinoso et al., 1996; Song et al., 2002; Li et al., 2013), which
is depicted in Figure 1B. Song et al. (2002) further observed
that decreased neurite outgrowth is associated with destabi-
lization of dendritic microtubule associated protein (MAP2)
by increased phosphorylation. Increased MAP2 phosphoryla-
tion is commonly associated with decreased neurite outgrowth
(Sanchez et al., 2000). However, activation of numerous kinases
causes MAP2 phosphorylation, providing an effector but not
the mechanism (Sanchez et al., 2000). An animal model of pre-
natal cocaine exposure also demonstrates the importance of
cortical D1 receptor signaling to suppress neurite outgrowth.
This model produces a long-lasting uncoupling of D1 recep-
tor signaling and concomitant increase in neurite outgrowth
(Jones et al., 2000; Stanwood and Levitt, 2007). Our group has
also observed increased basal neurite outgrowth in cortical cul-
tures derived from D1 receptor null embryos as compared to
cultures derived from wild-type littermates (unpublished data).
With regards to axonal effects, evidence suggests that D1-like
receptor stimulation also alters cortical axon growth patterns by
decreasing expression of the netrin-1 receptor (Sillivan, 2011).
In contrast to the growth-suppressing effects of D1-like recep-
tor stimulation, D2-like receptor activation in primary cortical
cultures leads to an increase in neurite outgrowth (illustrated in
Figure 1B; Todd, 1992; Reinoso et al., 1996). Thus, D1-like recep-
tor stimulation decreases neurite outgrowth and netrin-1 receptor
expression whereas D2-like receptor stimulation increases neurite
outgrowth in vitro. Yet, the DA receptor-expressing population
is only approximately 10–15% of neurons in the frontal cortex
(Santana et al., 2009). Ongoing research in our group is testing
whether these effects are cell-speciﬁc (only occurring in neurons
expressing DA receptors) or if a non-cell speciﬁc mechanism leads
to DA receptor-induced changes on neurite outgrowth in other
subpopulations.
In contrast, application of D1-like receptor agonists to stri-
atal neuronal cultures promotes neurite outgrowth, which can be
blocked with D1-like receptor antagonists and is demonstrated in
Figure 1B (Schmidt et al., 1996, 1998). This increased neurite out-
growth is associated with an increased number of growth cones
and arborization (Schmidt et al., 1998). However, D2-like recep-
tor activation shows no effect on striatal neurite outgrowth (also
demonstrated in Figure 1B; Schmidt et al., 1996). Hence, D1-like
receptor stimulation increases neurite outgrowth in the striatum
in vitro.
Studies from intact brains bolster the importance of develop-
mentalDAreceptor signalingondendritic growth inDA-richbrain
regions. Models of DA depletion (i.e., 6-OHDA treatment or mes-
encephalic lesion) show decreased expression of axon guidance-
and cytoskeletal growth-relatedproteins aswell as decreased length
of pyramidal layer V basal dendrites in frontal cortex (Kalsbeek
et al., 1989; Krasnova et al., 2007). In human studies, adolescents
exposed prenatally to cocaine display changes in cortical thick-
ness (Roussotte et al., 2012; Liu et al., 2013). MAP2 labeling of
D1 receptor knockout mice and diolistic labeling of rabbits pre-
natally exposed to cocaine show abnormal apical dendrites of
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cortical pyramidal cellswith decreasedbundling and increased tor-
tuous patterning (Jones et al., 2000; Stanwood et al., 2001a, 2005),
which supports the increased basal neurite outgrowth observed
in vitro. Conversely, silver impregnation of cortical neurons from
D1 receptor overexpressing mice show decreased apical dendrite
length compared to wild type littermates, which further supports a
role for D1 receptor signaling to promote dendritic growth (Song
et al., 2002). Finally, the Kellendonk lab has shown that mice
overexpressing D2 receptors in the striatum have decreased com-
plexity and length of striatal dendritic arbors (Cazorla et al., 2012).
Althoughdifferences innormal striatal dendriticmorphologyhave
been studied based on receptor subtype expression (Gertler et al.,
2008), to our knowledge the effects of reduced or absent D1
receptor signaling on striatal dendritic morphology has not been
examined.
SPINOGENESIS AND SYNAPTOGENESIS
Dendritic spinous processes start to form at the beginning of
synaptogenesis during the ﬁrst postnatal week and peak in ado-
lescence but continue to be structurally modiﬁed throughout
adulthood (Zhang and Benson, 2000). Spines develop from den-
dritic ﬁlopodia that interact with incoming axons, but some data
suggest that dendritic spines can form independent of axonal
interaction (Zhang and Benson, 2000; Whitford et al., 2002; Yuste
and Bonhoeffer, 2004). Dendritic spines are critical for synaptic
plasticity, allowing for compartmentalization of post-synaptic sig-
naling and synaptic specialization (Yuste and Bonhoeffer, 2001).
Additionally, alterations in spine density likely originating dur-
ing development are found in many neuropsychiatric diseases,
such as autism and schizophrenia (Kaufmann and Moser, 2000;
Garey, 2010; Penzes et al., 2011; Glausier and Lewis, 2013; Seshadri
et al., 2013). Importantly, DA plays a role in spinogenesis. For
example, a functional hyperdopaminergia, which occurs in DA
transporter (DAT) knockout mice, leads to a loss of proximal den-
dritic spines in striatal projection neurons (Berlanga et al., 2011).
This model also shows a behavioral phenotype of hyperactivity
and anxiety as well as altered mesocortical circuitry (Zhang et al.,
2010; Carpenter et al., 2012), and DA dysregulation occurs not
only during development, but continues into adulthood in this
model. Primate and rodent models of DA depletion also show
decreases in striatal dendritic spines (Ingham et al., 1989; Neely
et al., 2007;Villalba et al., 2009). Thus, a delicate balance of DA sig-
naling is required for formation/stabilization of dendritic spines.
Cortical pyramidal neurons of D1 and D2 receptor knockout mice
exhibit decreased dendritic spine density (Wang et al., 2009), and
moderate D1-like and D2-like receptor activation both have been
shown to increase spine density and spinophillin expression in
the striatum in vitro (Fasano et al., 2013). Studies have not yet
shown if higher concentrations of DAergic agonists, more like the
activation levels seen in the hyperdopaminergic DAT knockout
mouse, would phenocopy the decreased dendritic spine density
seen in that (potentially non-physiological) mutant. In fact, dur-
ing adolescence D2 receptor activation decreases striatal dendritic
spines (Jia et al., 2013). Interestingly, the spine loss in cortical pyra-
midal neurons resulting from DA depletion can be ameliorated
by spinogenesis-promoting antipsychotics like clozapine, provid-
ing further support for spine dysfunction in the pathology of
neuropsychiatric disease (Critchlow et al., 2006;Wang andDeutch,
2008).
Since dendritic spines serve as the recipients of synaptic input
and both develop concurrently, spinogenesis and synaptogene-
sis are intimately connected and are often co-regulated (Zhang
and Benson, 2000; Whitford et al., 2002; Yuste and Bonhoef-
fer, 2004; Haas, 2006). Multiple points of vulnerability beyond
spine formation can be altered to disrupt synaptogenesis. Axonal
pathﬁnding must lead to the vicinity of the target neuron for ini-
tial contact to be made. Cell-cell adhesion then needs to occur,
followed by pre- and post-synaptic differentiation and synapse
strengthening (Garner et al., 2002). Synapse formation, when
it occurs properly, leads to the formation of connections on
a particular part (usually dendritic spines) of a target neuron,
sometimes over very long distances (Südhof, 2006). Schizophre-
nia and other neurodevelopmental disorders are at least in part,
diseases of altered synaptic connectivity. Inappropriate dendritic
arborization, spinogenesis, and synaptic connections lead to inap-
propriate connectivity and altered excitation-inhibition balance
(McGlashan and Hoffman, 2000; Spronsen and Hoogenraad,
2010; Duman and Aghajanian, 2012). This is supported by
observations of decreased dendritic spines and synaptic label-
ing in post mortem cortex of schizophrenic patients (Glantz
and Lewis, 1997, 2000; Honer et al., 1999). Thus, synaptogenesis
can be altered by any of the previously discussed developmen-
tal events and plays an important role in neuropsychiatric disease
pathology.
Synaptogenesis follows a similar timeline of development as
spinogenesis and displays similar responses to DAergic modu-
lation. Synapses begin to form during the ﬁrst postnatal week
(Hattori and McGeer, 1973). The number of synapses peak dur-
ing adolescence, which is followed by synaptic pruning (Zhang
and Benson, 2000). In the striatum and frontal cortex, elec-
tron microscopy has shown that DAergic axons form symmetric
synapses similar to most GABAergic interneurons whereas glu-
tamatergic pyramidal axons forms asymmetric synapses (Smiley
et al., 1992; Antonopoulos et al., 2002; Yokofujita et al., 2008).
Neonatal DA depletion decreases the number of symmetric
synapses and changes the structure of asymmetric synapses
(Onténiente et al., 1980; Tennyson et al., 1982; Ingham et al., 1991,
1993). Others have suggested that neonatal DA depletion can
alter dendritic structures in the frontal cortex (Sherren and Pap-
pas, 2005), and cause dysregulation of gene expression patterns
required for normal brain architecture (Krasnova et al., 2007).
DA receptor antagonists can decrease prefrontal synapse density
whereas agonists slightly increased density (Sugahara and Shi-
raishi, 1998). Furthermore, haloperidol, a D2-like receptor antag-
onist, decreases hippocampal synaptic density in vitro (Critchlow
et al., 2006). Opposing D1 vs. D2 receptor developmental effects
are lost with regards to spinogenesis and synaptogenesis, and
hopefully further study will produce a mechanistic explanation.
DA lesion studies in adult animals support a continued role for
DA in the maintenance of corticostriatal synapses in the stria-
tum (for a comprehensive review of DA-regulated morphological
and electrophysiological changes, please seeArbuthnott et al., 2000
and Surmeier et al., 2011). Taken together, these studies support
a crucial role for DA in formation and stabilization of synaptic
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connections in the striatum and frontal cortex, providing fur-
ther evidence for developmental disruptions of DA and other
neurotransmitters in the structural pathology of neuropsychiatric
disease.
DOPAMINE D1 RECEPTOR SIGNALING MECHANISMS IN
DEVELOPMENTAL PROCESSES
Establishing a detailed signaling mechanism for the above men-
tioned in vitro and in vivo effects on developmental processes is
complicated by multiple signaling cascades and receptor interac-
tions. While all ﬁve DA receptors likely contribute to these effects
in speciﬁc ways, studies to date have predominantly examined
D1 receptors, and thus our discussion will also focus there. In
general, D1-like receptors transduce their signals by activating
adenylyl cyclase and increasing intracellular cAMP via Gαs/Gαolf
coupled proteins. Conversely, D2-like receptors typically trans-
duce their signals by inhibiting adenylyl cyclase and decreasing
cAMP (Missale et al., 1998; Beaulieu and Gainetdinov, 2011).
Intracellular cAMP activates protein kinase A (PKA), which phos-
phorylates proteins such as DA and cAMP-regulated phosphopro-
tein (DARPP-32) and cAMP responsive-element binding protein
(CREB;Parker et al., 1996; Greengard et al., 1999). CREBpromotes
transcription of geneswith cAMPresponse elements. Additionally,
MAPKs like extracellular signal-related kinase (ERK) are acti-
vated by D1 receptor stimulation and increase CREB signaling
(Missale et al., 1998).
DA receptors also participate in multiple non-Gα protein sig-
naling mechanisms. DA receptor mediated effects can involve
Gβ/Gγ proteins as well as other receptors (Missale et al., 1998;
Beaulieu and Gainetdinov, 2011). For example, D1 receptors
interact with NMDA receptors (Lee et al., 2002; Nai et al., 2010),
adenosine receptors (Fuxe et al., 2007; Shen et al., 2013), and neu-
rotrophin TrkB receptors (Iwakura et al., 2008), among others.
D2 receptors complex with adenosine A2A receptors (Canals et al.,
2003) and sigma-1 receptors (Navarro et al., 2013) and recruit pro-
tein kinase B/glycogen synthase kinase 3 (AKT/GSK3) signaling
pathways via a slower, cAMP-independent signaling mechanism
(Beaulieu et al., 2005, 2007). G protein-coupled receptor kinases
and arrestins, normally associated with receptor desensitization,
form a scaffold for D2 receptor interactions with protein phos-
phatase 2A and AKT. The resulting dephosphorylation of AKT
increases activity of GSK3, a target of lithium and many antipsy-
chotic drugs (Beaulieu et al., 2004; Li et al., 2007; Lovestone et al.,
2007).
Given the profound differences between how neurites of cor-
tical and striatal neurons respond to DA receptor agonists, it is
likely that intracellular signals are regulated in cell-speciﬁc ways.
These are difﬁcult experiments to carry out, however, and we
currently have a fairly superﬁcial understanding of these mecha-
nisms. Both D1-like receptor agonists and PKA activators increase
cortical MAP2 phosphorylation, decreasing the ability of MAP2
to stabilize the dendritic cytoskeleton and thus decreasing neu-
rite outgrowth (Song et al., 2002). Neurite outgrowth facilitation
by D1-like receptor stimulation in the striatum is also PKA-
dependent and at least in part CREB-mediated (Schmidt et al.,
1998). Additionally, the Chao lab has demonstrated that increased
neurite outgrowth in striatal cultures is at least partially dependent
on D1 receptor-mediated neurotrophin TrkB receptor activation.
Their study showed that D1-like receptor agonist treatment in
primary striatal cultures leads to activation and increased sur-
face expression of the TrkB receptor, and is accompanied by
phosphorylation of downstream Trk signaling proteins (Iwakura
et al., 2008). Thus, taken together, current evidence suggests that
the D1-like receptor-mediated changes in neurite outgrowth are
PKA-dependent in both cortex and striatum with an additional
neurotrophin TrkB receptor-dependent component only in the
striatum. The dichotomy betweenD1 andD2 receptor signaling in
the context of developmental dysfunction needs to be understood
in order to target the neurodevelopmental origins of neuropsychi-
atric disease. Furthermore, future studies should identify potential
roles for differences in G protein coupling (e.g., Gαs in cortex and
Gαolf in striatum Herve et al., 1993; Herve, 2011), and acces-
sory proteins with differential expression patterns (e.g., GPR88
in striatum Logue et al., 2009; Van Waes et al., 2011; Marley et al.,
2013).
GENETIC DISRUPTIONS OF DA SIGNALING AND
NEUROPSYCHIATRIC DISEASE
The DA system plays a fundamental role in psychotic disorders,
with D2 receptor antagonism being a major target for both typical
and atypical antipsychotics.WhileD2 receptor antagonismmay be
useful in controllingmanyof the positive symptoms in schizophre-
nia, emerging data implicates D1-like receptors as a target for
negative symptoms in schizophrenia (Goldman-Rakic et al., 2004;
Arnsten, 2013). In addition, several genetic perturbations in DA-
related genes have been found in patients with neuropsychiatric
disease. Patients with 22q11 deletion syndrome, which disrupts
DA-related genes (e.g., catechol-O-methyltransferase, COMT)
among others have an increased risk for neuropsychiatric disor-
ders, including schizophrenia-like psychosis, autism, and anxiety
disorders (Karam et al., 2010; Jonas et al., 2013). Hypomethyla-
tion of the COMT gene, which leads to an increase in the enzyme
that breaks down DA, has been associated with schizophrenia
and bipolar disorder (Abdolmaleky et al., 2006; Nohesara et al.,
2011). The translocation in the gene disrupted in schizophrenia-
1 (DISC-1) was originally found in a large Scottish family with
abnormally high rates of neuropsychiatric disease (Millar et al.,
2001). Interestingly, knockdown of DISC-1 in animal models
causes altered DAergic maturation and behavioral changes asso-
ciated with altered prefrontal cortex circuitry, suggesting a role
for DA in DISC-1 associated neuropsychiatric disease (Niwa et al.,
2010). Association studies implicate the A1 allele of the Taq1
polymorphism of DRD2 in the development of Tourette’s syn-
drome, ADHD, autism, PTSD, and alcoholism (Comings et al.,
1991). The Holden lab has found DA-related genes (DRD1,DRD2,
and PPP1R1B) associated with the severity of autism in families
with males only affected (Hettinger et al., 2008, 2012). Others have
found polymorphisms in DRD3 and DRD4 associated with autism
severity (de Krom et al., 2009; Gadow et al., 2010; Staal et al., 2012)
and DAT polymorphisms linked to bothADHD and bipolar disor-
der (Sharp et al., 2009). Additionally, polymorphisms in the gene
encoding thedownstreamsignalingproteinAkt are associatedwith
both bipolar disorder and schizophrenia (Thiselton et al., 2008;
Karege et al., 2012). While the effect sizes in these studies are not
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large, and the link toDA is sometimes indirect, taken together these
ﬁndings emphasize that disrupted DAergic homeostasis may be a
central mechanism in the risk of developing a neuropsychiatric
disorder.
CONCLUSION
There is strong evidence that DA plays a critical role in the gener-
ation of typical brain structure and function. DA and its cognate
receptors are present in the striatum and frontal cortex early in
brain development and contribute to the development of path-
ways needed for movement, cognition, and reward. Altered DA
signaling can affect the proliferation, migration, and differentia-
tion of speciﬁc subpopulations of neurons, and thus impact frontal
cortex and striatal neurocircuitry. D1 and D2 receptor subtypes
often have opposing effects on these developmental processes, and
the underlying mechanism for this dichotomy as well as the sig-
naling pathways that mediate these subtype-speciﬁc effects remain
mostly unknown.
Yet, DA is not the only neuromodulator that plays a role in
developmental processes. Serotonin is present before synapto-
genesis (Hansson et al., 1998) and alters neurite outgrowth and
axon pathﬁnding in vitro in a receptor-dependent manner (Lotto
et al., 1999; Persico et al., 2006; Bonnin et al., 2007; Tajiri et al.,
2012; Trakhtenberg and Goldberg, 2012; Anelli et al., 2013; Sper-
anza et al., 2013; for comprehensive review of roles of serotonin
in development, see van Kesteren and Spencer, 2003; Pino et al.,
2004; Bonnin and Levitt, 2011; Trowbridge et al., 2011). In addi-
tion, decreased cortical thickness in reelin mutants is postulated
to be driven by cortical cholinergic deprivation (Liu et al., 2001;
Sigala et al., 2007), and both nicotinic and muscarinic cholin-
ergic receptor manipulation alters neurite outgrowth (Lipton
et al., 1988; Pugh and Berg, 1994; Small et al., 1995; for com-
prehensive review, see Ruediger and Bolz, 2007; Dwyer et al.,
2009; Bruel-Jungerman et al., 2011). Finally, noradrenergic neu-
rons are thought form early synapses in the cortical plate and
mediate neuronal migration and laminar formation (Herlenius
and Lagercrantz, 2001). DA thus does not provide a singular
role in these developmental processes, and future studies will
need to address additional neuromodulators in combinatorial
patterns.
Our understanding of the role of developmental disruptions
of DA in the pathology of neuropsychiatric disorders is still
maturing. DA-rich areas, such as the prefrontal cortex and stria-
tum, are clearly dysfunctional in neuropsychiatric disorders like
schizophrenia, substance use disorders, and ADHD (Arnsten,
2006, 2011; Leppanen, 2006; Andersen and Teicher, 2009; Arnsten
et al., 2012). Developmental alterations in dendritic growth and/or
GABAergic interneuron migration likely contribute to the devel-
opment of pathology in these disorders (Beasley and Reynolds,
1997; Kaufmann and Moser, 2000; Black et al., 2004; Curley et al.,
2011). The increased DAergic inﬂuence in the cortex of primates
and dysfunction of DA-rich cortical areas in neuropsychiatric dis-
orders suggests an evolutionally increased role of DA, which has
also resulted in an evolutionarily increased vulnerability to dis-
ease. A new era of neuropsychiatric pharmacologic targets should
address the underlying pathology resulting from developmental
disruptions in DA and other neurotransmitters. Importantly, early
interventionshave themost positive impacts inneurodevelopmen-
tal disorders and learning disabilities (Bradshaw et al., 2012); our
hope is that a detailed mechanistic understanding of brain sub-
strates and developmental pharmacology will allow clinicians to
make similar rational interventions within neuropsychiatry.
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